Background and aim: The purpose of the present investigation is to provide an analysis of previous works on the epidemiology of the hepatitis C virus (HCV) infection from six countries throughout Latin America, to forecast the future HCV prevalence trends in Argentina, Brazil, Mexico and Puerto Rico, and to outline deficiencies in available data, highlighting the need for further research. Methods: Data references were identified through indexed journals and non-indexed sources. Overall, 1080 articles were reviewed and 150 were selected based on their relevance to this work. When multiple data sources were available for a key assumption, a systematic process using multi-objective decision analysis (MODA) was used to select the most appropriate sources. When data were missing, analogues were used. Data from other countries with similar risk factors and/or population compositions were used as a proxy to help predict the future trends in prevalence. Results: The review indicates that the dominant genotype is type 1. HCV prevalence in the analysed countries ranges from 1 to 2.3%. The Latin American countries have been very proactive in screening their blood supplies, thus minimizing the risk of transmission through transfusion. This suggests that other risk factors are set to play a major role in continued new infections. The number of diagnosed and treated patients is low, thereby increasing the burden of complications such as liver cirrhosis or hepatocellular carcinoma. The HCV prevalence, according to our modelling is steady or increasing and the number of infected individuals will increase. Conclusions: The results herein reported should provide a foundation for informed planning efforts to tackle hepatitis. © 2011 John Wiley & Sons A/S.31SUPPL. 21829Poynard, T., Yuen, M.F., Ratziu, V., Lai, C.L., Viral hepatitis C (2003) Lancet, 362, pp. 2095-2100El-Serag, H.B., Mason, A.C., Rising incidence of hepatocellular carcinoma in the United States (1999) N Engl J Med, 340, pp. 745-750Boyer, J.L., Chang, E.B., Collyar, D.E., Deleve, L.D., National Institutes of Health Consensus Development Conference (2002) management of hepatitis C: 2002, 36, pp. S1-S20. , HepatologyKershenobich, D., Razavi, H.A., Cooper, C.L., Applying a system approach to forecast the total HCV-infected population size-Model validation using US data (2011) Liver Int, 31 (SUPPL. 2), pp. 4-17Chiquete, E., Panduro, A., Low prevalence of anti-hepatitis C virus antibodies in Mexico (2007) A systematic review, 50, pp. 1-8. , IntervirologyAbdel-Hamid, M., El-Daly, M., El-Kafrawy, S., Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus (2002) J Clin Microbiol, 40, pp. 1656-1659IMS Health. IMS National Prescription Audit. July 27 2009. Available atMcHutchison, J.G., Lawitz, E.J., Shiffman, M.L., Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection (2009) N Engl J Med, 361, pp. 580-593Jacobson, I.M., Brown Jr, R.S., Freilich, B., Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients (2007) a randomized trial, 46, pp. 971-981. , HepatologyArmstrong, G.L., Wasley, A., Simard, E.P., The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 (2006) Ann Intern Med, 144, pp. 705-714Fay, O., Gonzalez, J., Rey, J., Blood donors and general population (2005) Acta Gastroenterol Latinoam, 35, pp. S11-S12Picchio, G.R., Bare, P.C., Descalzi, V.I., High prevalence of infection with a single hepatitis C virus genotype in a small rural community of Argentina (2006) Liver Int, 26, pp. 660-665Remesar, M., Gamba, C., Kuperman, S., Antibodies to hepatitis C and other viral markers in multi-transfused patients from Argentina (2005) J Clin Virol, 34 (SUPPL. 2), pp. S20-S26Weissenbacher, M., Rossi, D., Radulich, G., High seroprevalence of bloodborne viruses among street-recruited injection drug users from Buenos Aires, Argentina (2003) Clin Infect Dis, 37 (SUPPL. 5), pp. S348-S352Golemba, M.D., Di Lello, F.A., Bessone, F., High prevalence of hepatitis C virus genotype 1b infection in a small town of Argentina. Phylogenetic and Bayesian coalescent analysis (2010) PLoS One, 5, pp. e8751Insua, J.T., O'Flaherty, M., Frontera Vacca, M.J., (2005), 20 (SUPPL. 2), p. 185. , HCV infection (HCVI) prevalence in Argentine and impact of unsafe health care parenteral practices (HC-UPP): a seroprevalence survey. Society of General Internal Medicine 28th Annual Meeting, New Orleans, LA, 11-14 May. New Orleans, LA, USA: Society of General Internal Medicine. Journal of General Internal MedicineRidruejo, E., Adrover, R., Cocozzella, D., Fernandez, N., Reggiardo, M.V., Efficacy, tolerability and safety in the treatment of chronic hepatitis C with combination of PEG-Interferon-Ribavirin in daily practice (2010) Ann Hepatol, 9, pp. 46-51Epidemiology of viral hepatitis in Argentina] Epidemiologia de hepatitis virales en Argentina. Servicio Hepatitis y Gastroenteritis Departamento Virologia Laboratorio Nacional de Referencia Instituto Nacional de Enfermedades Infecciosas (INEI) Administracion Nacional de Laboratorios e Institutos de Salud (ANLIS) 'Dr Carlos Gregorio Malbran' 2009. Available at (accessed 6 January 2010)Re, V., Lampe, E., Yoshida, C.F., Hepatitis C virus genotypes in Cordoba, Argentina. Unexpected high prevalence of genotype 2 (2003) Medicina (B Aires), 63, pp. 205-210Oubina, J.R., Quarleri, J.F., Rudzinski, M., Genomic characterization of hepatitis C virus isolates from Argentina (1995) J Med Virol, 47, pp. 97-104Cruz, J.R., (2009) Supply of blood for transfusion in the Caribbean and Latin American countries in 2006-2007: progress since 2005 of the regional plan for transfusion safety, , Washington, DC: Pan American Health OrganizationSookoian, S., Castano, G., Castiglioni, T., The problem of hepatitis C virus infection in blood donors. Clinico-epidemiological, virological and histological evaluation (1997) Medicina (B Aires), 57, pp. 699-707Fassio, E., Schroder, T., Statement of the Argentinian Concensus on Hepatitis C 2007 (2008) Acta Gastroenterol Latinoam, 38, pp. 56-74Fainboim, H., Gonzalez, J., Fassio, E., Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study (1999) J Viral Hepatol, 6, pp. 53-57Perez Bianco, R., Santarelli, M.T., Analysis of a national serological survey for diseases transmitted by blood transfusion (1993) Medicina (B Aires), 53, pp. 491-496Cruz, J.R., (2002) Transfusion medicine in the Caribbean countries, 2000, , Washington, DC: Pan American Health OrganizationCruz, J.R., (2005) Medicina transfusional en los países del Caribe y Latinoamérica, 2000-2003. [Transfusion medicine in the Caribbean and Latin American Countries, 2001-2003], , Washington, DC: Organización Panamericana de la SaludQuarleri, J.F., Robertson, B.H., Mathet, V.L., Genomic and phylogenetic analysis of hepatitis C virus isolates from Argentine patients (2000) a six-year retrospective study, 38, pp. 4560-4568. , J Clin MicrobiolGismondi, M.I., Turazza, E.I., Grinstein, S., Galoppo, M.C., Preciado, M.V., Hepatitis C virus infection in infants and children from Argentina (2004) J Clin Microbiol, 42, pp. 1199-1202Quarleri, J.F., Robertson, B.H., Mathet, V., Genomic and phylogenetic analysis of hepatitis C virus strains from Argentina (1998) Medicina (B Aires), 58, pp. 153-159Bessone, F., Daruich, J., Lupo, S., Hepatitis C viral load is increased and related to genotype 1 in HCV+/HIV+co-infection compared with HCV+non-coinfected patients. Abstract # 598 (2003) Hepatology, 38, pp. 449AGismondi, M.I., Preciado, M.V., Badia, I., Genotype characterization of hepatitis C virus infection in children (2001) Medicina (B Aires), 61, pp. 815-820Di Lello, F., Garcia, G., Kott, V., Sookoian, S., Campos, R., Diversity of hepatitis C virus genotype 1b in Buenos Aires, Argentina (2008) description of a new cluster associated with response to treatment, 80, pp. 619-627. , J Med VirolParana, R., Vitvitski, L., Pereira, J.E., Hepatotropic viruses in the Brazilian Amazon (2008) a health threat, 12, pp. 253-256. , Braz J Infect DisGuia de vigilância epidemiológica (Guide to epidemiology surveillance), 7th ed, pp. 23-46. , Brasil: Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de DST A e H VClinical guidelines for hepatitis C 2007, Dispoe sobre Protocolo Clínico e Diretrizes Terapêuticas para Hepatite Viral C. 2007. Report No.: Portaria No. 34, de 28 de Setembro de 2007ID606503-0, , Brasil: Ministério da Saúde. Secretaria de Vigilancia em Saude. Departamento de DST AeHVPNpaPeoCdHVToledo, A.C., Greco, D.B., Felga, M., Seroprevalence of hepatitis B and C in Brazilian army conscripts in 2002 (2005) a cross-sectional study, 9, pp. 374-383. , Braz J Infect DisSilva, L., Parana, R., Mota, E., Prevalence of hepatitis C virus in urban and rural populations of northeast Brazil-pilot study (1995) Arq Gastroenterol, 32, pp. 168-171Cavalheiro, N.P., Barone, A.A., Tengan, F.M., HCV serotypes in Brazilian patients (2002) Int J Infect Dis, 6, pp. 228-232Brandao, A.B., Fuchs, S.C., Risk factors for hepatitis C virus infection among blood donors in southern Brazil (2002) a case-control study, 2, p. 18. , BMC GastroenterolSilva, G.F., Nishimura, N.F., Coelho, K.I., Soares, E.C., Grading and staging chronic hepatitis C and its relation to genotypes and epidemiological factors in Brazilian blood donors (2005) Braz J Infect Dis, 9, pp. 142-149Miranda, A.E., Figueiredo, N.C., Schmidt, R., Page-Shafer, K., A population-based survey of the prevalence of HIV, syphilis, hepatitis B and hepatitis C infections, and associated risk factors among young women in Vitoria, Brazil (2008) AIDS Behav, 12, pp. S25-S31Almeida, D., Tavares-Neto, J., Vitvitski, L., Serological markers of hepatitis A, B and C viruses in rural communities of the semiarid Brazilian northeast (2006) Braz J Infect Dis, 10, pp. 317-321Martins, R.M., Porto, S.O., Vanderborght, B.O., Short report (1995) prevalence of hepatitis C viral antibody among Brazilian children, adolescents, and street youths, 53, pp. 654-655. , Am J Trop Med HygSilva, G.F., Coelho, K.I., Nishimura, N.F., Soares, E.C., Progression of liver fibrosis in blood donors infected with hepatitis C virus (2004) Rom J Gastroenterol, 13, pp. 291-297Focaccia, R., Baraldo, D.C., Ferraz, M.L., Demographic and anthropometrical analysis and genotype distribution of chronic hepatitis C patients treated in public and private reference centers in Brazil (2004) Braz J Infect Dis, 8, pp. 348-355Focaccia, R., da Conceicao, O.J., Sette Jr, H., Estimated prevalence of viral hepatitis in the general population of the municipality of Sao Paulo, measured by a serologic survey of a stratified, randomized and residence-based population (1998) Braz J Infect Dis, 2, pp. 269-284Zarife, M.A., Silva, L.K., Silva, M.B., Prevalence of hepatitis C virus infection in north-eastern Brazil (2006) a population-based study, 100, pp. 663-668. , Trans R Soc Trop Med HygBrazil. Health Ministry. Health Surveillance Secretary. Department of STDs, AaVH, Brasil. Ministerio da Saude.Secretaria de Vigilancia em Saude. Departamento de DST, AeHV. [Viral hepatitis in numbers]. Brazil Minsitry of Health Department of STDs, AIDS and Viral Hepatitis 2010. Available at (accessed 9 December 2010)Aquino, J.A., Pegado, K.A., Barros, L.P., Machado, L.F., Seroprevalence of hepatitis B virus and hepatitis C virus infections among individuals in the State of Para (2008) Rev Soc Bras Med Trop, 41, pp. 334-337World population prospects: revision Population database ed, , United Nations: United Nations, New York, NY, USAParolin, M.B., Russo, A.A., de Almeida, P.T., Baldanzi, G.R., Lopes, R.W., Multicenter study on the prevalence of hepatitis C virus infection in blood donors in the city of Curitiba, Brazil (1999) Arq Gastroenterol, 36, pp. 117-121Paltanin, L.F., Reiche, E.M., Seroprevalence of anti-hepatitis C virus antibodies among blood donors, Brazil (2002) Rev Saude Publica, 36, pp. 393-399Rosini, N., Mousse, D., Spada, C., Treitinger, A., Seroprevalence of HbsAg, Anti-HBc and anti-HCV in Southern Brazil, 1999-2001 (2003) Braz J Infect Dis, 7, pp. 262-267Da Fonseca, J.C., Brasil, L.M., Hepatitis C virus infection in the Amazon Brazilian region (2004) Rev Soc Bras Med Trop, 37 (SUPPL. 2), pp. 1-8Valente, V.B., Covas, D.T., Passos, A.D., Hepatitis B and C serologic markers in blood donors of the Ribeirao Preto Blood Center (2005) Rev Soc Bras Med Trop, 38, pp. 488-492De Santana, N.P., De Freitas, L.A., Lyra, A.C., Liver histological alterations in patients with chronic hepatitis C and normal ALT levels in the city of Salvador, Northeast-Brazil (2005) Braz J Infect Dis, 9, pp. 134-141Andrade, A.F., Oliveira-Silva, M., Silva, S.G., Motta, I.J., Bonvicino, C.R., Seroprevalence of hepatitis B and C virus markers among blood donors in Rio de Janeiro, Brazil, 1998-2005 (2006) Mem Inst Oswaldo Cruz, 101, pp. 673-676Nascimento, M.C., Mayaud, P., Sabino, E.C., Torres, K.L., Franceschi, S., Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil (2008) a multi-center serosurvey, 80, pp. 53-57. , J Med VirolPerone, C., Del Castillo, D.M., Pereira, G.L., High prevalence of genotype 1 in individuals with hepatitis C in Belo Horizonte, MG (2008) Rev Soc Bras Med Trop, 41, pp. 238-242Silva, C.M., Costi, C., Krug, L.P., High proportion of hepatitis C virus genotypes 1 and 3 in a large cohort of patients from Southern Brazil (2007) Mem Inst Oswaldo Cruz, 102, pp. 867-870Martins, R.M., Teles, S.A., Freitas, N.R., Distribution of hepatitis C virus genotypes among blood donors from mid-west region of Brazil (2006) Rev Inst Med Trop Sao Paulo, 48, pp. 53-55Amorim, R.M., Oliveira, C.P., Wyant, P.S., Hepatitis C virus genotypes in blood donors from the Federal District, Central Brazil (2004) Mem Inst Oswaldo Cruz, 99, pp. 895-897Vogler, I.H., Nishiya, A., Morimoto, H.K., Serological, epidemiological and molecular aspects of hepatitis C virus infection in a population from Londrina, PR, Brazil, 2001-2002 (2004) Rev Inst Med Trop Sao Paulo, 46, pp. 303-308Campiotto, S., Pinho, J.R., Carrilho, F.J., Geographic distribution of hepatitis C virus genotypes in Brazil (2005) Braz J Med Biol Res, 38, pp. 41-49Pereira, L.M., Spinelli, V., Ximenes, R.A., Chronic hepatitis C infection (2002) influence of the viral load, genotypes, and GBV-C/HGV coinfection on the severity of the disease in a Brazilian population, 67, pp. 27-32. , J Med VirolSilva, L.K., Parana, R., Souza, S.P., Hepatitis C virus genotypes in a northeastern area of Brazil (2000) Am J Trop Med Hyg, 62, pp. 257-260Oliveira, M.L., Bastos, F.I., Sabino, R.R., Distribution of HCV genotypes among different exposure categories in Brazil (1999) Braz J Med Biol Res, 32, pp. 279-282Parana, R., Vitvitski, L., Berby, F., HCV infection in northeastern Brazil (2000) unexpected high prevalence of genotype 3a and absence of African genotypes, 37, pp. 213-216. , Arq GastroenterolKrug, L.P., Lunge, V.R., Ikuta, N., Hepatitis C virus genotypes in Southern Brazil (1996) Braz J Med Biol Res, 29, pp. 1629-1632Brasil.Ministerio da Saude.Secretaria de Vigilancia em Saude.Departamento de DST AeHV. [Hepatitis C-Distribution of confirmed cases in Brazil by region, 1980-2005]. Brasil Ministério da Saúde Secretaria de Vigilancia em Saude Departamento de DST,Aids e Hepatites Virais 2010. Available atBrasil. Ministerio da Saude, Secretaria de Vigilancia em Saude, Departamento de DST AeHV. [Hepatitis, by region/by state and year, Brazil, from 1999 to 2007. Tables and graphs]. Brasil Ministério da Saúde Secretaria de Vigilancia em Saude Departamento de DST, Aids e Hepatites Virais 2009. Available atValdespino, J.L., Conde-González, C.J., Olaiz-Fernández, G., Seroprevalence of hepatitis C among Mexican adults (2007) an emerging public health problem?, 49, pp. s395-s403. , Salud pública MéxVera De Leon, L., Juarez Navarro, J.A., Diaz Gomez, M., Epidemiologic and situational panorama of hepatitis C in Mexico (2005) Rev Gastroenterol Mex, 70, pp. 25-32Rivas-Estilla, A.M., Cordero-Perez, P., Trujillo-Murillo Kdel, C., Genotyping of hepatitis C virus (HCV) in infected patients from Northeast Mexico (2008) Ann Hepatol, 7, pp. 144-147Garcia-Montalvo, B.M., Seropositivity of HIV, HBV, HCV and Treponema pallidum in blood donors in southeast Mexico (2006) Rev Invest Clin, 58, pp. 567-572Benitez-Arvizu, G., Cortez-Gomez, R., Novelo-Garza, B.A., Prevalence of hepatitis C virus in the blood bank at Centro Medico Nacional La Raza (2006) Rev Med Inst Mex Seguro Soc, 44, pp. 227-233Chiquete, E., Sanchez, L.V., Becerra, G., Performance of the serologic and molecular screening of blood donations for the hepatitis B and C viruses in a Mexican Transfusion Center (2005) Ann Hepatol, 4, pp. 275-278Carreto-Velez, M.A., Carrada-Bravo, T., Martinez-Magdaleno, A., Seroprevalence of HBV, HCV, and HIV among blood donors in Irapuato, Mexico (2003) Salud Publica Mex, 45 (SUPPL. 5), pp. S690-S693Ladron-de Guevara, L., Gomez, N., Vazquez-Cantarell, M., Garcia-Mendez, S., Di Silvio, M., Prevalence of and risk factors for hepatitis C in blood donors (2002) Rev Gastroenterol Mex, 67, pp. 11-16Alvarez-Munoz, M.T., Vences-Aviles, M.A., Damacio, L., Hepatitis C virus RNA (HCV-RNA) in blood donors and family members seropositive for anti-HCV antibodies (2001) Arch Med Res, 32, pp. 442-445Mendez-Sanchez, N., Baptista-Gonzalez, H., Sanchez-Gomez, R.H., Bordes-Aznar, J., Uribe-Esquivel, M., The prevalence of hepatitis B and C in blood donors in a 3rd-level hospital of Mexico City (1999) Salud Publica Mex, 41, pp. 475-478Ayala Gaytan, J.J., Guerra Avalos, F.J., Moro Brondo, P., Casillas Romo, A., Prevalence of viral markers for hepatitis B, C and human immunodeficiency virus in volunteer blood donors in Northeast Mexico (1997) Rev Gastroenterol Mex, 62, pp. 250-253Pita-Ramirez, L., Torres-Ortiz, G.E., Prevalence of viral antibodies and syphilis serology in blood donors from a hospital (1997) Rev Invest Clin, 49, pp. 475-480Islas, S., Yamaguchi, K., Nishimura, Y., Antibody to hepatitis C virus in volunteer blood donors of the Hospital de Especialidades, National Medical Center, Mexico City (1994) Arch Med Res, 25, pp. 361-362Merino-Conde, E., Orozco, J.A., Rojo-Medina, J., Tovar, A., Prevalence of hepatitis C virus among candidates for blood donation at the Hospital General de Mexico (1994) In Vivo, 8, pp. 621-623Hernandez-Perez, R.E., Frias-Salcedo, J.A., Del Angel-Guevara, O., The seroprevalence of antibodies against the hepatitis C virus in blood donors at the Hospital Central Militar (1994) Salud Publica Mex, 36, pp. 538-540Cervantes Bustamante, R., Ramirez Mayans, J.A., Jiron, C.R., Prevalence of antibodies against hepatitis C virus (HCV) in a population of Mexican children (1996) Acta Gastroenterol Latinoam, 26, pp. 301-303Mendez-Sanchez, N., Ponciano-Rodriguez, G., Chavez-Tapia, N.C., Prevalence of hepatitis C infection in a population of asymptomatic people in a checkup unit in Mexico city (2005) Dig Dis Sci, 50, pp. 733-737Santos-Lopez, G., Sosa-Jurado, F., Vallejo-Ruiz, V., Melendez-Mena, D., Reyes-Leyva, J., Prevalence of hepatitis C virus in the Mexican population (2008) a systematic review, 56, pp. 281-290. , J InfectDehesa-Violante, M., Bosques-Padilla, F., Kershenobich-Stalnikowitz, D., Prevalence of hepatitis C virus genotypes in Mexican patients (2007) Rev Gastroenterol Mex, 72, pp. 344-348Jimenez-Mendez, R., Uribe-Salas, F., Lopez-Guillen, P., Cisneros-Garza, L., Castaneda-Hernandez, G., Distribution of HCV genotypes and HCV RNA viral load in different regions of Mexico (2010) Ann Hepatol, 9, pp. 33-39Perez, C.M., Marrero, E., Melendez, M., Seroepidemiology of viral hepatitis, HIV and herpes simplex type 2 in the household population aged 21-64 years in Puerto Rico (2010) BMC Infect Dis, 10, p. 76Rodriguez-Perez, F., Suarez-Perez, E., Alvarez-Rohena, M., Toro, D.H., Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico (2004) P R Health Sci J, 23, pp. 49-56Reyes, J.C., Colon, H.M., Robles, R.R., Prevalence and correlates of hepatitis C virus infection among street-recruited injection drug users in San Juan, Puerto Rico (2006) J Urban Health, 83, pp. 1105-1113Lopez-Navedo, P.J., Lebron-Rivera, R., Gonzalez-Trapaga, J., Prevalence of hepatitis C virus infection at three hemodialysis units in the western region of Puerto Rico (1999) Bol Asoc Med P R, 91, pp. 100-102Sanchez, L.P., Flynn, J.M., Mayol, M., Seroprevalence of blood borne transmissible diseases in trauma orthopaedic surgical patients (1998) P R Health Sci J, 17, pp. 113-116Deseda, C.C., Sweeney, P.A., Woodruff, B.A., Prevalence of hepatitis B, hepatitis C, and human immunodeficiency virus infection among women attending prenatal clinics in San Juan, Puerto Rico, from 1989-1990 (1995) Obstet Gynecol, 85, pp. 75-78Perez, C.M., Suarez, E., Torres, E.A., Roman, K., Colon, V., Seroprevalence of hepatitis C virus and associated risk behaviours (2005) a population-based study in San Juan, Puerto Rico, 34, pp. 593-599. , Int J EpidemiolColon, H.M., Robles, R.R., Deren, S., Between-city variation in frequency of injection among Puerto Rican injection drug users (2001) East Harlem, New York, and Bayamon, Puerto Rico, 27, pp. 405-413. , J Acquir Immune Defic SyndrDeren, S., Oliver-Velez, D., Finlinson, A., Integrating qualitative and quantitative methods (2003) comparing HIV-related risk behaviors among Puerto Rican drug users in Puerto Rico and New York, 38, pp. 1-24. , Subst Use MisuseDeren, S., Robles, R., Andia, J., Trends in HIV seroprevalence and needle sharing among Puerto Rican drug injectors in Puerto Rico and New York (2001) 1992-1999, 26, pp. 164-169. , J Acquir Immune Defic SyndrFerrandiz, Q.J., Paz, V., Cabrera, C., Guillermo Almenara Irigoyen State Hospital, Lima, Peru. Perfil epidemiológico y clínico de la hepatitis crónica C en el Hospital Guillermo Almenara Irigoyen, 2004, Lima-Peru, Conversation with: Razavi HA, Center for Disease Analysis, Kromite, Louisville, Colorado, USA, 2010de Los Rios, R., Bussalleu, A., Hurtado, A., Prevalence of anti hepatitis C antibodies in patients with chronic renal failure receiving conservative therapy (2006) Rev Gastroenterol Peru, 26, pp. 265-270Mendez Chacon, P., Vidalon, A., Vildosola, H., Risk factors for hepatitis C in hemodialysis and its impact on the waiting list for kidney transplantation (2005) Rev Gastroenterol Peru, 25, pp. 12-18Colichon Yerosh, A., Figueroa, R., Moreno, A., Serologic prevalence of HCV antibodies in health personnel in Peru (2004) Rev Gastroenterol Peru, 24, pp. 13-20Valdivia, J.A., Rivera, S., Ramirez, D., Hepatitis C virus infection in female sexual workers from northern Lima (2003) Rev Gastroenterol Peru, 23, pp. 265-268Diaz Diaz, C.T., (2002) Seroepidemiological study of heaptitis C in hemodialysis, , Lima, Peru: Universidad Nacional Mayer de San Marcos (Lima), Faculty of Medicine Graduate SchoolSanchez, J.L., Sjogren, M.H., Callahan, J.D., Hepatitis C in Peru (2000) risk factors for infection, potential iatrogenic transmission, and genotype distribution, 63, pp. 242-248. , Am J Trop Med HygFarfan, G., Cabezas, C., Prevalence of viral hepatitis type C in blood donors in Peru (2003) Rev Gastroenterol Peru, 23, pp. 171-176Ferrandiz, J., Colaretta, M., Barreda, C., (2000) Genotipo predominante del virus hepatitis C en el Peru, , Peru: Revista de Gastroenterolgia del PeruMonsalve-Castillo, F., Costa, L., Callejas-V, Incidencia del virus de hepatitis c en etnias Yukpas y Bari de La Sierra de Perijá. Estado Zulia. Venezuela. Sociedad Venezolana de Microbiología 2005. Available atCuadra-Sanchez, C., Moronta-Pinango, R., Cordova-Villanueva, E., Seroprevalence of hepatitis C virus (HCV) in patients of the Regional Viral Reference Laboratory (Maracaibo, Venezuela) (2005) Rev Gastroenterol Peru, 25, pp. 248-253Rojas, N., Sanchez, D., Rodriguez, J., Seroprevalence of anti-VHC, coexistence of Ag-HBs, anti-HBc and HIV and a risk factor anti-VHC donors (2003) Postgrad Med Bull, 19 (1), pp. 9-17Monsalve-Castillo, F., Gomez-Gamboa, L., Albillos, A., [Hepatitis C virus in populations at risk for infection. Venezuela] (2007) Rev Esp Enferm Dig, 99, pp. 315-319Fortes, M., Trompiz, A., Canonico, Y., Vargas-Lovelle, B., Machado, I.V., Hepatitis C virus genotype 1 frequency has not varied in Venezuela (2009) Rev Colomb Gastroenterol, 24, pp. 256-258Pujol, F.H., Loureiro, C.L., Replacement of hepatitis C virus genotype 1b by genotype 2 over a 10-year period in Venezuela (2007) J Clin Gastroenterol, 41, pp. 518-520Te, H.S., Jensen, D.M., Epidemiology of hepatitis B and C viruses (2010) a global overview, 14, pp. 1-21. , Clin Liver DisMendez-Sanchez, N., Gutierrez-Grobe, Y., Kobashi-Margain, R.A., Epidemiology of HCV infection in Latin America (2010) Ann Hepatol, 9 (SUPPL.), pp. 27-29Sy, T., Jamal, M.M., Epidemiology of hepatitis C virus (HCV) infection (2006) Int J Med Sci, 3, pp. 41-46Robinson, J.W., Rosas, M., Guzman, F., Patarroyo, M.E., Moreno, A., Comparison of prevalence of anti-hepatitis C virus antibodies in differing South American populations (1996) J Med Virol, 50, pp. 188-192Cristina, J., Genetic diversity and evolution of hepatitis C virus in the Latin American region (2005) J Clin Virol, 34 (SUPPL. 2), pp. S1-S7